Browsing by Author Tsang, FH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 3 to 22 of 25 < previous   next >
TitleAuthor(s)Issue DateViews
 
Chromatin remodeler HELLS is an epigenetic driver for hepatocellular carcinoma progression
Proceeding/Conference:Cancer Research
Law, CTWei, LLTsang, FHChan, CYXu, MJILai, RKHo, DWHLee, JKMWong, CCLNg, IOLWong, CM
2017
47
 
Clinical implication of ectopic expression of microRNA-125b in liver cancer
Proceeding/Conference:Cancer Omics
Tsang, FHLuk, JMCLee, NPY
2010
101
 
Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma
Journal:Oncogene
Fatima, SLee, NPTsang, FHKolligs, FTNg, IOLPoon, RTPFan, STLuk, JM
2012
171
 
Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis
Journal:Hepatology
Au, LKSWong, CCLLee, MFFan, NYTsang, FHNg, IOLWong, CM
2012
203
 
Expression of ankyrin repeat and SOCS box containing 4 (ASB4) confers migration and invasion properties of hepatocellular carcinoma cells
Journal:BioScience Trends
Au, CHVTSANG, FHMan, KFan, STPoon, RTPLee, NPY
2014
54
 
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma
Journal:Journal of Clinical Investigation
LEE, DXU, MCHIU, KCLAI, KHTse, PWLi, LLLAW, CTTsang, FHWei, LCHAN, YKWong, CMNg, IOLWong, CCL
2017
144
 
Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer
Journal:Oncogenesis
Tse, APSze, KMShea, QTChiu, EYTsang, FHChiu, DKZhang, MSLee, DXu, IMChan, CYKoh, HYWong, CMZheng, YPNg, IOL
2018
 
Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b
Journal:Hepatology
Fan, NYTsang, FHTam, HKAAu, LKSWong, CCLWei, LLee, MFHe, XHNg, IOLWong, CM
2013
72
 
Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3
Journal:Journal of Hepatology
Wei, LChiu, KCTsang, FHLaw, CTCheng, LHCAu, LKSLee, MFWong, CCLNg, IOLWong, CM
2017
2
 
Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma
Journal:Nature Communications
CHIU, KCTse, PWXU, MCui, DLAI, KHLi, LLKoh, HYTsang, FHWEI, LWong, CMNg, IOLWong, CCL
2017
135
 
In vivo genome-wide CRISPR activation screening identifies functionally important long non-coding RNAs in hepatocellular carcinoma.
Journal:Cell Mol Gastroenterol Hepatol
WONG, LSWei, LWANG, GLAW, CTTsang, FHChin, WCNg, IOLWong, CM
2022
 
Lysyl Oxidase-like 2 Is Critical To Tumor Microenvironment And Metastatic Niche Formation In Hepatocellular Carcinoma
Journal:Hepatology
Wong, CCLTse, PWHuang, YZhu, YCHIU, KCLAI, KHAu, LKSKai, AKLLee, MFWEI, LTsang, FHLo, CLRShi, JZheng, YWong, CMNg, IOL
2014
101
 
MicroRNA-125b as a negative regulator for eukaryotic translation initiation factor 5A2 (eIF5A2) in liver cancer
Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2009 and 6th RCC Annual Meeting
Tsang, FHLuk, JMCLee, NPY
2009
95
 
MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility
Journal:Frontiers of Medicine
Tsang, FHAu, LKSWei, LFan, NYLee, MFWong, CCLNg, IOLWong, CM
2015
139
 
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
Journal:Nature Reviews Gastroenterology & Hepatology
Wong, CMTsang, FHNg, IOL
2018
79
 
Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2
Journal:Digestive Diseases and Sciences
TSANG, FHAu, CHVLU, WSHEK, HPLIU, MLLuk, JMCFan, STPoon, RTPLee, NPY
2014
52
 
Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma
Journal:International Journal of Cancer
Lee, NPTsang, FHShek, FHMao, MDai, HZhang, CDong, SGuan, XYPoon, RTPLuk, JM
2010
182
 
Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma
Journal:Journal of Proteome Research
Lee, NPChen, LLin, MCTsang, FHYeung, CPoon, RTPeng, JLeng, XBeretta, LSun, SDay, PJLuk, JM
2009
 
Regulation of hepatocarcinogenesis by microRNAs.
Journal:Front Biosci (Elite Ed)
Wong, CMKai, KLATsang, FHNg, IOL
2013
46
 
RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2
Journal:Hepatology
Chen, MWei, LLaw, DCTsang, FHShen, JCheng, CLTsang, LHHo, DWHChiu, DKLee, JKMWong, CCLNg, IOLWong, CM
2018
212
Showing results 3 to 22 of 25 < previous   next >